Experience 3 days packed with science, clinical updates, and unrivaled networking.
The ESTS Annual Meeting has a strong tradition of delivering a premier scientific program that expertly balances groundbreaking research with practical, advanced clinical discussions vital to the general thoracic surgery specialty.
This tradition continues in the 34th Meeting of the ESTS. The program has been meticulously updated to accurately reflect the rapid advancements and contemporary landscape of thoracic surgery, covering essential topics from translational clinical research to innovative surgical techniques.
Join us on 7-9 June 2026, in the historic and vibrant city of Athens, Greece, for this defining event in thoracic surgery.
The Conference program starts at 8:00 AM on Sunday, 7 June 2026.
Please note the program is subject to changes.



Join us at the premier international event dedicated to thoracic surgery.
The world’s foremost experts in thoracic surgery and allied health professions will gather to present and discuss the latest advancements in surgical techniques, translational research, patient care strategies, and emerging technologies. This is where the future of our specialty is shaped.
100+
Speakers
82
Symposia
17
Industry symposia
7
Forum discussions
6
Plenary lectures
I especially appreciated the diversity and depth of the scientific content. The integration of basic and translational research with updates on clinical trials created a well-rounded perspective on neurodegenerative disease research. I also enjoyed the opportunities for networking and collaboration, as well as the accessibility of sessions both in person and virtually. The possibility of seeing the virtual sessions was particularly important.
Excellent mix of very mechanistic science, translational work, and clinical research. It truly bridged the gap between lab and clinic.
The scientific program is fascinating. Diverse topics and research lines are addressed and brilliantly generate new questions at the same time as answering some.
Great overview of new treatments and biomarkers from industry and academia, all of which are well integrated.
Be part of the next chapter of the Meeting of the ESTS
Whether you are an established professional looking to update your expertise, or an emerging surgeon or healthcare professional seeking to connect with mentors, ESTS 2026 promises a dynamic, interactive, and informative experience for all.
AD/PD™ is an inspiring convergence of cutting-edge science and real-world clinical application. I was most impressed by the integration of neurodegeneration biomarkers with precision medicine approaches, offering hope for earlier and more targeted interventions. The collaborative spirit and energy among researchers, clinicians, and innovators truly stood out — it felt like the future of brain health is being shaped right now.